Protech Home Medical (CVE:PTQ) and Smith & Nephew (CNSX:SNN) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for Protech Home Medical and Smith & Nephew, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Protech Home Medical | 0 | 0 | 5 | 0 | 3.00 |
Smith & Nephew | 0 | 0 | 0 | 0 | N/A |
Protech Home Medical presently has a consensus price target of C$2.58, suggesting a potential upside of 20.16%.
Profitability
This table compares Protech Home Medical and Smith & Nephew's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Protech Home Medical | N/A | N/A | N/A |
Smith & Nephew | N/A | N/A | N/A |
Valuation and Earnings
This table compares Protech Home Medical and Smith & Nephew's top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Protech Home Medical | C$82.22 million | 2.95 | $-5,417,568.00 | C($0.05) | -44.79 |
Smith & Nephew | N/A | N/A | N/A | N/A | N/A |
Smith & Nephew has lower revenue, but higher earnings than Protech Home Medical.
Summary
Protech Home Medical beats Smith & Nephew on 2 of the 2 factors compared between the two stocks.